China NMPA Product Recall - Intra-aortic balloon counterpulsation catheter, intra-aortic balloon counterpulsation catheter and accessories

The National Medical Products Administration (NMPA) issued a significant announcement on May 20, 2024, regarding a Class I voluntary recall initiated by Arrow International LLC. This action was reported by Telefel Medical Devices Trading (Shanghai) Co., Ltd. and involves specific intra-aortic balloon counterpulsation catheters and their associated accessories. The critical nature of this recall, designated as Class I, indicates that the use of or exposure to these affected products carries a reasonable probability of causing serious adverse health consequences or even death. The fundamental issues prompting this recall include reports of a small number of products exhibiting critical malfunctions: incomplete inflation of the intra-aortic balloon and breakage of the device's central lumen. These defects are particularly serious for a medical device designed to assist the heart's pumping function, as they could compromise patient safety and therapeutic efficacy. As a required action, Arrow International LLC is voluntarily recalling the identified medical devices to mitigate potential risks and uphold product quality standards. Further specific details regarding the affected product batches are available in the accompanying 'Medical Device Recall Event Report Form', ensuring transparency and facilitating the recall process under NMPA's regulatory oversight.